Anaplasmosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anaplasmosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07312474

Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

Anaplasmosis is a bacterial infection caused by the intracellular bacterium Anaplasma phagocytophilum and transmitted by ticks. This bacterium is present in app…

France100 participantsStarted 2024-10-02

All recent trials (5 shown)

WithdrawnNot Applicable

NCT03932448

Fever After Tick Bite Study

The proposed study is a collaboration between Microbiology, SU/Sahlgrenska and the Infectious Diseases clinic at SU/Östra as well as several Infectious Diseases…

Sweden0Started 2019-05-15

Treatment: The proposed study is not interventional.

CompletedPhase 2/3

NCT00237016

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

Abstract Background Tick-Borne Relapsing Fever (TBRF) is an acute febrile illness. In Israel, TBRF is caused by Borrelia persica and is transmitted by Ornithodo…

Israel140 participantsStarted 2002-04

Treatment: doxycycline treatment

Anaplasmosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

All recent trials (5 shown)

Fever After Tick Bite Study

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

All recent trials (5 shown)

Fever After Tick Bite Study

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

Human Anaplasmosis in Eastern France